Julian Adams
Chairman at ELICIO THERAPEUTICS, INC.
Net worth: 24 806 $ as of 2024-04-29
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Robert Connelly | M | 63 |
Elicio Therapeutics, Inc. (Old)
 Elicio Therapeutics, Inc. (Old) BiotechnologyHealth Technology Elicio Therapeutics, Inc. engages in the development of vaccines for infectious disease and cancer. Its programs focus on a novel lipid nanocapsule platform technology for delivering vaccines in a form mimicking the structure of pathogens to elicit potent immunity in prophylactic and therapeutic settings. The company was founded by Satish Jindal and Darrell Irvine on August 10, 2011 and is headquartered in Cambridge, MA. | 6 years |
| Robert Ruffolo | M | 74 |
Elicio Therapeutics, Inc. (Old)
Elicio Therapeutics, Inc. (Old) BiotechnologyHealth Technology Elicio Therapeutics, Inc. engages in the development of vaccines for infectious disease and cancer. Its programs focus on a novel lipid nanocapsule platform technology for delivering vaccines in a form mimicking the structure of pathogens to elicit potent immunity in prophylactic and therapeutic settings. The company was founded by Satish Jindal and Darrell Irvine on August 10, 2011 and is headquartered in Cambridge, MA. | 6 years |
| Thomas Bures | M | 49 | 7 years | |
| Carol Ashe | F | 66 |
Elicio Therapeutics, Inc. (Old)
Elicio Therapeutics, Inc. (Old) BiotechnologyHealth Technology Elicio Therapeutics, Inc. engages in the development of vaccines for infectious disease and cancer. Its programs focus on a novel lipid nanocapsule platform technology for delivering vaccines in a form mimicking the structure of pathogens to elicit potent immunity in prophylactic and therapeutic settings. The company was founded by Satish Jindal and Darrell Irvine on August 10, 2011 and is headquartered in Cambridge, MA. | 4 years |
| Seth Tasker | M | 45 | 16 years | |
| Anthony Evnin | M | 83 |
Infinity Discovery, Inc.
| 23 years |
| Norman Selby | M | 71 |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | 21 years |
| Megan Filoon | F | - | 1 years | |
| James Geraghty | M | 69 | 7 years | |
| Peter DeMuth | M | 38 |
Elicio Therapeutics, Inc. (Old)
Elicio Therapeutics, Inc. (Old) BiotechnologyHealth Technology Elicio Therapeutics, Inc. engages in the development of vaccines for infectious disease and cancer. Its programs focus on a novel lipid nanocapsule platform technology for delivering vaccines in a form mimicking the structure of pathogens to elicit potent immunity in prophylactic and therapeutic settings. The company was founded by Satish Jindal and Darrell Irvine on August 10, 2011 and is headquartered in Cambridge, MA. | 7 years |
| Michael Burns | M | - |
Princess Margaret Cancer Foundation
| 6 years |
| Ann J. Barbier | M | 59 | 6 years | |
| Christopher Haqq | M | 58 |
Elicio Therapeutics, Inc. (Old)
Elicio Therapeutics, Inc. (Old) BiotechnologyHealth Technology Elicio Therapeutics, Inc. engages in the development of vaccines for infectious disease and cancer. Its programs focus on a novel lipid nanocapsule platform technology for delivering vaccines in a form mimicking the structure of pathogens to elicit potent immunity in prophylactic and therapeutic settings. The company was founded by Satish Jindal and Darrell Irvine on August 10, 2011 and is headquartered in Cambridge, MA. | 5 years |
| Annette Matthies | M | 47 |
Elicio Therapeutics, Inc. (Old)
Elicio Therapeutics, Inc. (Old) BiotechnologyHealth Technology Elicio Therapeutics, Inc. engages in the development of vaccines for infectious disease and cancer. Its programs focus on a novel lipid nanocapsule platform technology for delivering vaccines in a form mimicking the structure of pathogens to elicit potent immunity in prophylactic and therapeutic settings. The company was founded by Satish Jindal and Darrell Irvine on August 10, 2011 and is headquartered in Cambridge, MA. | 3 years |
| Esther Welkowsky | F | - |
Elicio Therapeutics, Inc. (Old)
Elicio Therapeutics, Inc. (Old) BiotechnologyHealth Technology Elicio Therapeutics, Inc. engages in the development of vaccines for infectious disease and cancer. Its programs focus on a novel lipid nanocapsule platform technology for delivering vaccines in a form mimicking the structure of pathogens to elicit potent immunity in prophylactic and therapeutic settings. The company was founded by Satish Jindal and Darrell Irvine on August 10, 2011 and is headquartered in Cambridge, MA. | 4 years |
| Janice Fukakusa | F | 69 |
Princess Margaret Cancer Foundation
| - |
| Mary Coelho | F | 62 | 1 years | |
| Christopher Kiritsy | M | 59 | 8 years | |
| Karen Wilson | F | 61 | 1 years | |
| Yekaterina Chudnovsky | F | 39 | 2 years | |
| Allen Nissenson | M | 77 | 4 years | |
| Vladimir Melnikov | M | - | 3 years | |
| Jack Fleischmann | M | - |
Princess Margaret Cancer Foundation
| - |
| Candace Innes | F | - |
Princess Margaret Cancer Foundation
| - |
| Christy Morrow | F | - |
Princess Margaret Cancer Foundation
| - |
| Richard J. Cohen | M | 73 |
Massachusetts Institute of Technology
| 45 years |
| M. Marianne Harris | F | 66 |
Princess Margaret Cancer Foundation
| - |
| Helen M. Hicks | F | 63 |
Princess Margaret Cancer Foundation
| - |
| Christina Kramer | F | - |
Princess Margaret Cancer Foundation
| - |
| Fiorella Kostoris | F | 79 |
Massachusetts Institute of Technology
| 44 years |
| Andrew Hoffman | M | 62 |
Princess Margaret Cancer Foundation
| 8 years |
| Andrew Irvine | M | 72 |
Princess Margaret Cancer Foundation
| 8 years |
| Annie Ropar | F | - |
Princess Margaret Cancer Foundation
| 7 years |
| Ronit Simantov | M | 59 | 7 years | |
| Mary-Alice Vuicic | F | 56 |
Princess Margaret Cancer Foundation
| 10 years |
| Jay Venkatesan | M | 52 | - | |
| Stuart Waugh | M | - |
Princess Margaret Cancer Foundation
| 10 years |
| Jochen Tilk | M | 60 |
Princess Margaret Cancer Foundation
| - |
| David Shaw | M | 71 |
Princess Margaret Cancer Foundation
| - |
| Richard Elgin Rooney | M | - |
Princess Margaret Cancer Foundation
| 7 years |
| Joy Seymour | F | - | 2 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Lawrence Bloch | M | 58 | 11 years | |
| Richard Kogan | M | 81 | 21 years | |
| Christopher M. Lindblom | M | 52 | 8 years | |
| Ofer Gonen | M | 50 |
Elicio Therapeutics, Inc. (Old)
Elicio Therapeutics, Inc. (Old) BiotechnologyHealth Technology Elicio Therapeutics, Inc. engages in the development of vaccines for infectious disease and cancer. Its programs focus on a novel lipid nanocapsule platform technology for delivering vaccines in a form mimicking the structure of pathogens to elicit potent immunity in prophylactic and therapeutic settings. The company was founded by Satish Jindal and Darrell Irvine on August 10, 2011 and is headquartered in Cambridge, MA. | 7 years |
| Gerald Quirk | M | 56 | 6 years | |
| Darlene Deptula-Hicks | F | 66 | - | |
| Joshua D. Hamermesh | M | 51 | 3 years | |
| Eric S. Lander | M | 67 |
Infinity Discovery, Inc.
| 15 years |
| Jaren Madden | F | - | 7 years | |
| Franklin H. Moss | M | 75 |
Infinity Discovery, Inc.
| 10 years |
| Shawn Tomasello | F | 65 | 5 years | |
| Steven Kafka | M | 54 | 6 years | |
| Allan Reine | M | 49 | 2 years | |
| Lance Thibault | M | 58 | 1 years | |
| Abbey Jenkins | F | - | 2 years | |
| James Tananbaum | M | 60 |
Infinity Discovery, Inc.
| 11 years |
| Yael Margolin | M | 70 | 14 years | |
| Mark A. Clements | M | - |
Massachusetts Institute of Technology
| 3 years |
| Vito Palombella | M | 61 |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | 14 years |
| Thomas Lynch | M | 63 | 5 years | |
| Heather DiVecchia | F | - | 6 years | |
| Yoo-Hwan Jang | M | 69 |
Massachusetts Institute of Technology
| 3 years |
| Assaf Segal | M | 51 |
Elicio Therapeutics, Inc. (Old)
Elicio Therapeutics, Inc. (Old) BiotechnologyHealth Technology Elicio Therapeutics, Inc. engages in the development of vaccines for infectious disease and cancer. Its programs focus on a novel lipid nanocapsule platform technology for delivering vaccines in a form mimicking the structure of pathogens to elicit potent immunity in prophylactic and therapeutic settings. The company was founded by Satish Jindal and Darrell Irvine on August 10, 2011 and is headquartered in Cambridge, MA. | 1 years |
| Steven Holtzman | M | 70 |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | 18 years |
| Samuel Minzberg | M | 67 |
McGill University
| 11 years |
| Patrick Lee | M | 67 |
Infinity Discovery, Inc.
| 11 years |
| Henry Hoppe | M | - |
Massachusetts Institute of Technology
| 7 years |
| Tom A. Stefanick | M | - |
Massachusetts Institute of Technology
| 5 years |
| On-kwok Li | M | 69 |
Massachusetts Institute of Technology
| 3 years |
| Glenn Ives | M | 62 |
Princess Margaret Cancer Foundation
| 9 years |
| Jocelyn E. Scott | F | - |
Massachusetts Institute of Technology
| 4 years |
| Peter Zieve | M | 70 |
Massachusetts Institute of Technology
| 3 years |
| Jeffrey Berkowitz | M | 58 | 6 years | |
| Beth A. Marcus | M | - |
Massachusetts Institute of Technology
| 5 years |
| Barbara Poggiali | M | 61 |
Massachusetts Institute of Technology
| 5 years |
| Jolie Siegel | F | 48 | 2 years | |
| Terence S. Orstlan | M | - |
McGill University
| 6 years |
| J. Wargo | M | 69 |
Massachusetts Institute of Technology
| 6 years |
| Gregg Burgess | M | - |
Massachusetts Institute of Technology
| 5 years |
| Tom Maniatis | M | 80 |
ProScript, Inc.
 ProScript, Inc. Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., ProScript, Inc. is a company that develops anti-cancer treatments. The company is based in Cambridge, MA. The company was founded by Tom Maniatis. ProScript was acquired by LeukoSite, Inc., part of Takeda Pharmaceutical Co., Ltd. from December 22, 1999 on July 20, 1999 for $3.35 million. | - |
| Paul Arnison | M | - |
McGill University
| 6 years |
| Caroline Dorsa | F | 64 | 22 years | |
| Marsha Fanucci | F | 70 |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | 9 years |
| John Bishop | M | 62 |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | 4 years |
| Charles Homcy | M | 75 |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | 6 years |
| Kevin Starr | M | 61 |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | 4 years |
| Kenneth Moch | M | 69 | 8 years | |
| Brian Jacobs | M | 63 |
Massachusetts Institute of Technology
| 5 years |
| John Robert Chisholm | M | - |
Massachusetts Institute of Technology
| 7 years |
| José Baselga | M | 65 | 3 years | |
| Ian Smith | M | 58 | 11 years | |
| Marino Carol | F | - | 8 years | |
| Paul Alofs | M | - |
Princess Margaret Cancer Foundation
| 15 years |
| Perry Ha | M | 62 |
Massachusetts Institute of Technology
| 6 years |
| Dave Grayzel | M | 56 | 8 years | |
| Montgomery Alger | M | 67 |
Massachusetts Institute of Technology
| 5 years |
| Peter F. Smith | M | 66 |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | - |
| Kenneth Bartizal | M | 72 | 20 years | |
| Don Shulsinger | M | - |
Massachusetts Institute of Technology
| 6 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 71 | 71.00% |
| Canada | 21 | 21.00% |
| Israel | 11 | 11.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Julian Adams
- Personal Network
